However, neither of the treatment groups was associated with the reduction in MHD, whereas MHD at baseline was (M3: \(\beta\)= 0.29, 95% CI 0.46, 0.11
But some say these medications didnt work for them due to side effects or lack of progress
With intensifying competition, GLP-1 receptor agonists will continue to be the core growth driver influencing the development of pipelines and market entry strategies
When CVS Caremark removed Zepbound from its standard formularies in July 2025, Aetna commercial plans followed
Does that mean that people need to take these drugs forever
Glossary of common terms GLP-1 RA (Glucagon-Like Peptide-1 Receptor Agonist): A class of medicines that mimic the GLP-1 hormone to improve insulin secretion, reduce appetite, and slow stomach emptying